Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 3-((R)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid | 126453-07-4 | 99.0% | 252.20 g·mol⁻¹ | C8H17N2O5P | 25 MG
SDP

Catalog No. 5000211777
Encompass_Preferred

(R)-CPP is the R-enantiomer of CPP, a potent competitive N-methyl-D-aspartate (NMDA) receptor antagonist used as a research reagent in neuropharmacology and electrophysiology. It is provided as a high-purity solid for in vitro and in vivo studies and is not for human or clinical use.

  • Highly potent NMDA receptor antagonist suitable for receptor pharmacology.
  • R-enantiomer with greater activity than the racemic mixture.
  • High reported purity (98.99%).
  • Solid form with defined molecular weight and formula (252.20 g·mol⁻¹; C8H17N2O5P).
  • Commonly used in electrophysiology and glutamatergic signaling studies.

Catalog No. 50-002-11777 Supplier Medchemexpress LLC Supplier No. HY10081425MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(R)-CPP is the R-enantiomer of CPP, a potent competitive N-methyl-D-aspartate (NMDA) receptor antagonist used as a research reagent in neuropharmacology and electrophysiology. It is provided as a high-purity solid for in vitro and in vivo studies and is not for human or clinical use.

  • Highly potent NMDA receptor antagonist suitable for receptor pharmacology.
  • R-enantiomer with greater activity than the racemic mixture.
  • High reported purity (98.99%).
  • Solid form with defined molecular weight and formula (252.20 g·mol⁻¹; C8H17N2O5P).
  • Commonly used in electrophysiology and glutamatergic signaling studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.